Alfieri Michael Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$13,250.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Alfieri Michael

According to the SEC Form 4 filings, Alfieri Michael, being in a position of

  1. Principal Financial Officer at Aldeyra Therapeutics, Inc.,
    оver the last 12 months, has bought 2500 shares for $13,250, and sold 0 shares,
    over all time since 2025-08-13, has bought 2500 shares for $13,250, and sold 0 shares.

Biography of Alfieri Michael

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $13,2501100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-01-23SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Legal Officer & Corp Sec
5,633
0.0089%
$1.90$10,718+4.06%
2026-01-23SaleACRES Commercial Realty Corp.
ACR
10 percent owner
1,100
–
$22.02$24,222-9.45%
2026-01-23PurchaseAlly Financial Inc.
ALLY
Chief Executive Officer
23,800
0.0078%
$41.68$991,867-1.33%
2026-01-23SaleAmprius Technologies, Inc.
AMPX
Chief Technology Officer
1,600
0.0013%
$12.00$19,200-6.96%
2026-01-23SaleCentury Aluminum Company
CENX
President and CEO
150,000
0.159%
$48.19$7.23M+1.08%
2026-01-23SaleClene Inc.
CLNN
10 percent owner
5,556
0.0593%
$5.27$29,280+0.76%
2026-01-23SaleDakota Gold Corp.
DC
CHIEF EXECUTIVE OFFICER
250,000
0.2215%
$6.88$1.72M-0.34%
2026-01-23SaleEos Energy Enterprises, Inc.
EOSE
Chief Legal Officer
41,667
0.0181%
$17.74$739,173-3.55%
2026-01-23PurchaseIRIDEX Corporation
IRIX
Chief Financial Officer
5,221
0.0295%
$1.48$7,716+2.85%
2026-01-23SaleLSB Industries, Inc.
LXU
director
15,926
0.0225%
$10.03$159,738-1.55%
2026-01-23PurchaseAmerican Strategic Investment Co.
NYC
10 percent owner
1,365
0.0533%
$10.38$14,169-4.14%
2026-01-23PurchasePeoples Bancorp Inc.
PEBO
director
157
0.0004%
$31.65$4,969-0.79%
2026-01-23PurchaseRLI Corp.
RLI
CHIEF OPERATING OFFICER
2,000
0.0022%
$57.99$115,980-1.78%
2026-01-23PurchaseRLI Corp.
RLI
CHIEF EXECUTIVE OFFICER
5,000
0.0055%
$57.45$287,250-0.85%
2026-01-23SaleSES AI Corporation
SES
CHIEF SCIENCE OFFICER
100,000
0.029%
$2.50$250,320-4.12%
2026-01-23PurchaseSol-Gel Technologies Ltd.
SLGL
10 percent owner
1,151
0.0396%
$55.98$64,434+4.39%
2026-01-23PurchaseW. R. Berkley Corporation
WRB
10 percent owner
368,000
0.0966%
$66.96$24.64M+0.24%
2026-01-23SaleYelp Inc.
YELP
Chief Executive Officer
30,000
0.0484%
$28.74$862,301-1.61%
2026-01-22SaleAbeona Therapeutics Inc.
ABEO
SVP, Chief Legal Officer
13,578
0.0249%
$5.33$72,383-1.59%
2026-01-22SaleAbeona Therapeutics Inc.
ABEO
Chief Financial Officer
18,666
0.0343%
$5.33$99,507-1.59%
Total: 845185
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.